Evidence map›Paper›PMID 27322243›Full record

ArticleInternational journal of molecular sciences2016

Novel Double-Hit Model of Radiation and Hyperoxia-Induced Oxidative Cell Damage Relevant to Space Travel.

Ralph A Pietrofesa, Anastasia Velalopoulou, Stacey L Lehman, Evguenia Arguiri, Pantelis Solomides, Cameron J Koch, Om P Mishra, Constantinos Koumenis, Thomas J Goodwin, Melpo Christofidou-Solomidou

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ralph A PietrofesaDivision of Pulmonary, Allergy, and Critical Care Medicine and the Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Edward J. Stemmler Hall 2nd Floor, Office Suite 227, Philadelphia, PA 19104, USA. ralphp@mail.med.upenn.edu.
Anastasia VelalopoulouDivision of Pulmonary, Allergy, and Critical Care Medicine and the Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Edward J. Stemmler Hall 2nd Floor, Office Suite 227, Philadelphia, PA 19104, USA. avela@mail.med.upenn.edu.
Stacey L LehmanDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. staceylehman87@gmail.com.
Evguenia ArguiriDivision of Pulmonary, Allergy, and Critical Care Medicine and the Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Edward J. Stemmler Hall 2nd Floor, Office Suite 227, Philadelphia, PA 19104, USA. evguenia@mail.med.upenn.edu.
Pantelis SolomidesDivision of Pulmonary, Allergy, and Critical Care Medicine and the Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Edward J. Stemmler Hall 2nd Floor, Office Suite 227, Philadelphia, PA 19104, USA. pantelis.solomides@temple.edu.
Cameron J KochDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. kochc@mail.med.upenn.edu.
Om P MishraDivision of Pulmonary, Allergy, and Critical Care Medicine and the Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Edward J. Stemmler Hall 2nd Floor, Office Suite 227, Philadelphia, PA 19104, USA. mishra.o@gmail.com.
Constantinos KoumenisDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. costas.Koumenis@uphs.upenn.edu.
Thomas J GoodwinThe National Aeronautics and Space Administration (NASA) Johnson Space Center, Houston, TX 77058, USA. tgoodwin3@comcast.net.
Melpo Christofidou-SolomidouDivision of Pulmonary, Allergy, and Critical Care Medicine and the Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Edward J. Stemmler Hall 2nd Floor, Office Suite 227, Philadelphia, PA 19104, USA. melpo@mail.med.upenn.edu.
University of Pennsylvania · USNational Aeronautics and Space Administration · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
Environmental Science Project 3 - Social Determinants of Risk and Attitudes AboutP42ES023720 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2014 to 2018
$11.3M
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation PheumonopathyR01CA133470 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOFIDOU-SOLOMIDOU, MELPO · 2008 to 2012
$2.2M
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATIONR21AT008291 · NCCIH · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOFIDOU-SOLOMIDOU, MELPO, WINKELSTEIN, BETH A · 2015 to 2016
$440k
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)R03CA180548 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOFIDOU-SOLOMIDOU, MELPO · 2013 to 2014
$137k
NCCIH NIH HHS R21 AT008291NCI NIH HHS R01 CA133470NCI NIH HHS R03 CA180548NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P42 ES023720
6 · The paper itself

Abstract

Spaceflight occasionally requires multiple extravehicular activities (EVA) that potentially subject astronauts to repeated changes in ambient oxygen superimposed on those of space radiation exposure. We thus developed a novel in vitro model system to test lung cell damage following repeated exposure to radiation and hyperoxia. Non-tumorigenic murine alveolar type II epithelial cells (C10) were exposed to >95% O₂ for 8 h only (O₂), 0.25 Gy ionizing γ-radiation (IR) only, or a double-hit combination of both challenges (O₂ + IR) followed by 16 h of normoxia (ambient air containing 21% O₂ and 5% CO₂) (1 cycle = 24 h, 2 cycles = 48 h). Cell survival, DNA damage, apoptosis, and indicators of oxidative stress were evaluated after 1 and 2 cycles of exposure. We observed a significant (p < 0.05) decrease in cell survival across all challenge conditions along with an increase in DNA damage, determined by Comet analysis and H2AX phosphorylation, and apoptosis, determined by Annexin-V staining, relative to cells unexposed to hyperoxia or radiation. DNA damage (GADD45α and cleaved-PARP), apoptotic (cleaved caspase-3 and BAX), and antioxidant (HO-1 and Nqo1) proteins were increased following radiation and hyperoxia exposure after 1 and 2 cycles of exposure. Importantly, exposure to combination challenge O₂ + IR exacerbated cell death and DNA damage compared to individual exposures O₂ or IR alone. Additionally levels of cell cycle proteins phospho-p53 and p21 were significantly increased, while levels of CDK1 and Cyclin B1 were decreased at both time points for all exposure groups. Similarly, proteins involved in cell cycle arrest was more profoundly changed with the combination challenges as compared to each stressor alone. These results correlate with a significant 4- to 6-fold increase in the ratio of cells in G2/G1 after 2 cycles of exposure to hyperoxic conditions. We have characterized a novel in vitro model of double-hit, low-level radiation and hyperoxia exposure that leads to oxidative lung cell injury, DNA damage, apoptosis, and cell cycle arrest.

Indexed as

DNA DamageHyperoxiaModels, BiologicalOxidative StressRadiation, IonizingSpace FlightAlveolar Epithelial CellsAnimalsAntioxidantsApoptosisCell CycleCell SurvivalGene Expression RegulationGene Expression Regulation, EnzymologicHistonesHumansAntioxidantsHistonesReactive Oxygen Speciesand space explorationcell cycleDNA damageextravehicular activityhyperoxiaionizing radiationlung cell injuryoxidative stressreactive oxygen species

Identifiers

PMID27322243
PMCPMC4926486
OpenAlexW2435274812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.